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The N-methyl-D-Aspartate glutamate receptors (NMDARs) are pivotal for the functional
and morphological plasticity that are required in neuronal networks for efficient brain
activities and notably for cognitive-related abilities. Because NMDARs are heterogeneous
in subunit composition and associated with multiple functional regulatory sites, their
efficacy is under the tonic influence of numerous allosteric modulations, whose
dysfunction generally represents the first step generating pathological states. Among the
enzymatic candidates, serine racemase (SR) has recently gathered an increasing interest
considering that it tightly regulates the production of D-serine, an amino acid now viewed
as the main endogenous co-agonist necessary for NMDAR activation. Nowadays, SR
deregulation is associated with a wide range of neurological and psychiatric diseases
including schizophrenia, amyotrophic lateral sclerosis, and depression. This review
aims at compelling the most recent experimental evidences indicating that changes
in SR-related modulation of NMDARs also govern opposite functional dysfunctions in
physiological and pathological (Alzheimer’s disease) aging that finally results in memory
disabilities in both cases. It also highlights SR as a relevant alternative target for new
pharmacological strategies aimed at preventing functional alterations and cognitive
impairments linked to the aging process.
Keywords: NMDA receptors, serine racemase, aging, Alzheimer’s disease, D-serine, long term potentiation,
glutamate
INTRODUCTION
Through the fine regulation of neurotransmitters/neuromodulators availability at their respective
binding sites, enzymatic activities are critical for normal brain functions and are generally targeted
by pathophysiological processes. In this context, the modulation of the N-methyl-D-Aspartate
subtype of glutamate receptors (NMDARs) certainly represents a school case, which actually
focuses the attention of a large proportion of the scientific community as illustrated by the almost
5,000 review articles referenced in pubmed. In fact, based on their large distribution throughout
the nervous system and their diversity in subunit composition associated with regional specificity
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in the brain and even with segregated localization at synapse level
(see Paoletti et al., 2013; Zhu and Paoletti, 2015), NMDARs thus
appear as a perfect example to evaluate the impact of specific
allosteric regulation of selective brain activities and notably
of cognitive capacities, in normal and pathological conditions.
These receptors are complex entities under the modulation of
a wide range of regulatory processes driven by magnesium,
polyamines and histamine environments as well as levels of redox
state (Johnson and Ascher, 1990; Kleckner and Dingledine, 1991;
Lipton et al., 1998; Choi and Lipton, 2000; Brown et al., 2001;
Haas et al., 2008; Zhu and Paoletti, 2015). Beside these salient
regulation features, NMDAR activation is also characterized by
the obligatory fixation in addition to the main agonist glutamate
of a co-agonist at a specific binding site (Traynelis et al., 2010;
Paoletti, 2011; Paoletti et al., 2013). Attributed initially to glycine
(Johnson and Ascher, 1987, 1992; Kleckner and Dingledine,
1988), this role of co-agonist in much brain area and particularly
in those involved in cognitive functions, is now devoted to
D-serine (Schell et al., 1997; Mothet et al., 2000; Snyder and Kim,
2000; Shleper et al., 2005; Billard, 2008, 2012; Henneberger et al.,
2012; Bardaweel et al., 2014; Wolosker, 2018), a D-amino acid
produced by the racemisation of L-serine by the enzyme serine
racemase (SR) (Wolosker et al., 1999). Like the degradation of
D-serine (Mothet et al., 2000; Shleper et al., 2005; Strick et al.,
2011; Papouin et al., 2012; Rosenberg et al., 2013; Le Bail et al.,
2015), the genetic deletion of SR impairs the connectivity and
the functional plasticity of neuronal networks and has been
associated with cognitive impairments (Inoue et al., 2008, 2018;
Basu et al., 2009; Labrie et al., 2009; Balu and Coyle, 2012; Bai
et al., 2014; Puhl et al., 2017; Balu et al., 2018). Consequently,
changes in SR-dependent modulation of NMDAR activation
through alterations of synaptic availability of D-serine, have
been postulated to contribute to pathophysiological mechanisms
governing several neurological diseases [reviewed in Billard
(2013) and Coyle and Balu (2018)]. Thus, weaker NMDAR
activation linked to down regulation of SR activity is now viewed
as a critical synaptic dysfunction in schizophrenia, addictions,
anxiety disorders, and depression (Coyle, 2006; Benneyworth and
Coyle, 2012; Gómez-Galán et al., 2012; Coyle and Balu, 2018). On
the opposite, up regulation of NMDAR activity due to increased
production of D-serine by SR is viewed as a central mechanism
for neurodegenerative processes underlying the amyotrophic
lateral sclerosis (Sasabe et al., 2007; Lee et al., 2017; Kondori et al.,
2018).
In the last decades, the role of SR-dependent regulation of
NMDAR activity in cognitive aging has also been investigated,
that is the focus of the present review. After recapitulating our
knowledge that now considers NMDAR modulation by SR as an
essential mechanism involved in learning and memory, currently
available information related to its deregulation in physiological
aging and Alzheimer’s disease (AD) will be presented, with the
main conclusion that a strict regulation of SR activity is required
for a successful cognitive aging. This review could also offer
new opportunities for considering new relevant pharmacological
strategies specifically targeting the SR-associated pathway to treat
memory deficits linked to age-related brain disorders.
NMDA RECEPTORS: STRUCTURE AND
FUNCTIONAL REGULATION
NMDARs are part of a large multiprotein complex at
glutamatergic synapses, that have received much attention
over the last decades, due to their role in many types of
neural plasticity on the one hand, and their involvement in
neurotoxicity on the other hand. They are hetero-tetramers
generally formed by two GluN1 subunits associated with the
combination of two other partners including either four distinct
GluN2 (GluN2A-D) or a mixture of GluN2 with two different
GluN3 (GluN3A and 3B) subunits (Ulbrich and Isacoff, 2008;
Traynelis et al., 2010; Paoletti, 2011; Paoletti et al., 2013)
(Figure 1). The GluN1 subunit is expressed throughout the
brain since it is mandatory for NMDAR activation through the
necessary binding of a co-agonist at the amino-terminal domain
of the extracellular region (Ballard et al., 2002; Paoletti et al.,
2013). Besides, GluN2 subunits specifically bind the main agonist
glutamate and differ from each other by their pharmacological
profiles and also by providing distinct functional properties to
NMDARs (Nakanishi and Masu, 1994; Dingledine et al., 1999;
Hofmann et al., 2000; Paoletti et al., 2013). Although the wide
range of subunit associations predicts a large diversity within the
NMDARs family, preferential combinations have been regionally
detected in the brain that is also observed at synaptic levels where
GluN2A and GluN2B subunits are enriched at postsynaptic
densities and extrasynaptic zones respectively (Traynelis et al.,
2010; Paoletti, 2011; Paoletti et al., 2013). Important in the
context of aging, GluN1 expression remains elevated throughout
lifespan (Laurie and Seeburg, 1994; Monyer et al., 1994) whereas
a progressive decrease in the GluN2B/GluN2A ratio generally
occurs with age at cortical synapses (Monyer et al., 1994; Stocca
and Vicini, 1998; Liu et al., 2004; Swanger and Traynelis, 2018),
that have suggested the interest of pharmacologically targeting
the GluN2B subunit to treat or prevent age-related memory
decline (Wang et al., 2014).
In contrast to their diversity in subunit composition,
all NMDARs are structurally homogenous (Figure 1) and
characterized by three helices (M1, M3, M4) and a hairpin
(M2) that form a transmembrane domain allowing the ion
selectivity of the receptors. While this domain is subjected to
tonic modulation, notably by magnesium (Mg2+), this is not the
case for the cytoplasmic carboxy-terminal intracellular domain
that controls the coupling to different intracellular signaling
cascades and the receptor trafficking (Traynelis et al., 2010;
Paoletti, 2011; Paoletti et al., 2013).
Compared to the other subtypes of ionotropic glutamate
receptors, NMDARs display distinct functional properties
identified by slow gating and deactivating kinetics associated
with high calcium permeability, which depend on the subunit
composition (Dunah et al., 1999; Paoletti, 2011; Wyllie et al.,
2013; Zhang and Luo, 2013; Sun et al., 2017). In addition to
their specific voltage-dependent blockade by Mg2+ (Johnson
and Ascher, 1990; Kleckner and Dingledine, 1991), another
impressive functional feature of NMDARs consists in their
activation processes which require not only the binding of
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FIGURE 1 | Schematic representation of the assembly and modular organization of a N-Methyl-D-Aspartic acid receptor (NMDAR). The extracellular segment
includes the N-terminal domain (NTD) and the agonist binding domain (ABD) where D-serine /glycine and glutamate bind to the GluN1 and GluN2 subunit respectively.
ABD also contains the redox and polyamine regulatory sites. The ion channel is localized in the transmembrane domain (TMD) that contains the site for the
magnesium blockade while the C-terminal domain (CTD) is included in the intracellular segment.
glutamate on GluN2 subunits but in synergy, the fixation of a
co-agonist on a specific site present on the GluN1 components
(Traynelis et al., 2010; Paoletti, 2011). This necessity of a
dual binding was initially characterized in the late 80s when
the induction magnitude of inward currents through native
or NMDARs expressed in oocytes (Kleckner and Dingledine,
1988) or in cultured mouse neurons (Johnson and Ascher,
1987) was found to closely rely on glycine levels present in the
external medium, thus revealing the existence of the so-called
glycine-binding site. After more than 20 years of biochemical,
immunohistochemical and electrophysiological investigations
[reviewed in Billard (2012)], the initial view of glycine as the
endogenous NMDAR co-agonist has then been progressively
substituted by the concept assigning this role to the amino acid D-
serine, though the most recent emerging view now considers that
D-serine rather cooperates with glycine in a complex interplay to
control NMDAR activation following time and space constraints
(Mothet et al., 2015). D-serine is directly converted from its
precursor enantiomer L-serine by the activity of the pyridoxal
5-phosphate (PLP)-dependent enzyme serine racemase (SR)
(Wolosker et al., 1999). Interestingly, this enzyme is also able to
metabolize D-serine into pyruvate and ammonia by catalyzing
an α,β elimination of water (De Miranda et al., 2002; Foltyn
et al., 2005). This reaction may represent an alternative route
to degrade D-serine in forebrain regions where the endogenous
degrading enzyme D-amino acid oxidase DAAO (Pollegioni et al.,
2007), is poorly expressed (Bendikov et al., 2007; Verrall et al.,
2007; Jagannath et al., 2017). However, since the efficacy of the
racemisation process of L-serine is five times higher than the
reaction of α, β elimination (Strísovský et al., 2005), one generally
considers that SR preferentially governs D-serine synthesis.
SERINE RACEMASE: LOCALIZATION,
REGULATION AND CONTRIBUTION TO
FUNCTIONAL PLASTICITY AT SYNAPSES
Nowadays, the question to know if SR is expressed in a
specific cellular population at synapses is heavily discussed and
has broadened to the larger debate asking if D-serine may
be considered as a gliotransmitter like glutamate and ATP
(Wolosker et al., 2016, 2017; Papouin et al., 2017). Indeed, the
initial characterization of SR expression in astrocytes (Wolosker
et al., 1999) and the view that different NMDAR-dependent
functions could be driven by a vesicular release of D-serine
from this subtype of glial cells (Yang et al., 2005; Panatier et al.,
2006; Williams et al., 2006; Martineau et al., 2008; Papouin
et al., 2012; Martineau, 2013; Lalo et al., 2018; Robin et al.,
2018) are now strongly questioned. This is mainly due to the
development of more selective SR antibodies and improved
immunohistochemical protocols, to the lack in those pre-cited
experiments of negative controls with SR knock-out (SR−/−)
mice which display a 90% decrease in brain D-serine without
significant changes in levels of the other amino acids except
D-aspartate (Miya et al., 2008; Basu et al., 2009), and finally
because the use of mice with disrupted SNARE-dependent
exocytosis in astrocytes to specifically assess glio-transmission
is still under debate (Fiacco and McCarthy, 2018; Savtchouk
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and Volterra, 2018). When rigorous experimental conditions are
achieved in vivo, SR is mainly expressed in excitatory neurons
and GABAergic inhibitory interneurons of the human and
rodent brains with only a weak if any detection in astrocytes
(Kartvelishvily et al., 2006; Miya et al., 2008; Benneyworth et al.,
2012; Ehmsen et al., 2013; Balu et al., 2014; Perez et al., 2017).
Nowadays, an emerging concept of a serine shuttle gathers
increasing interest (Wolosker, 2011;Wolosker and Radzishevsky,
2013) in which it is viewed that through orchestrated activities
of neutral amino acid transporters including at least alanine-
serine-cysteine 1 (Asc-1) and ASCT1 subtypes (Rosenberg et al.,
2013; Sason et al., 2017; Kaplan et al., 2018), the astrocyte-
derived precursor L-serine fuels the neuronal SR to produce
D-serine, which is then released to bind NMDAR before to
be subsequently removed from synapses by either neurons or
astrocytes (Figure 2). Although this shuttle sounds attractive to
account for the synaptic turnover of D-serine in the healthy
brain though it needs to be definitively validated, it fails to work
when pathological conditions associated with astrogliosis prevail,
such as those occurring in traumatic brain injury for example.
Indeed, a controlled cortical brain insult results in a down-
regulation of neuronal SR expression and a parallel increase
in reactive astrocytes (Perez et al., 2017), that thus devotes a
major role in vivo to glia-derived D-serine only when pathological
mechanisms inducing excitotoxic damages and neuronal death
are promoted.
In addition to help for a better determination cellular
localization of SR, lessons from SR−/− mice have also provided
information for a pivotal role of the SR-associated processes
in controlling functional plasticity at synapses. This has been
particularly investigated using the electrophysiological paradigm
of long-term potentiation (LTP) of synaptic transmission, a form
of long lasting form of synaptic plasticity now viewed as a major
functional requirement for memory formation (Izquierdo, 1991;
Bear and Malenka, 1994; Collingridge and Bliss, 1995; Izquierdo
and Medina, 1995; Lisman and McIntyre, 2001; Kim and Linden,
2007). Indeed, LTP is significantly reduced ex vivo in slice
preparations isolated from mice with specific deletion of SR in
neurons using the calmodulin kinase II promoter or in vivo using
the Thy1-mediated Cre recombination, the deficits being rescued
in both cases by exogenous D-serine (Benneyworth et al., 2012;
Perez et al., 2017). On the contrary, similar designs but selectively
targeting astrocytes using the GFAP promoter has no significant
impact on LTP expression (Benneyworth et al., 2012). These
results provide additional functional evidences that SR-induced
D-serine from glia plays a minor role in synaptic plasticity in
healthy conditions, in opposition to what is claimed (Panatier
et al., 2006; Henneberger et al., 2010; Papouin et al., 2012;
Lalo et al., 2018). However, it is worth noting that glia-derived
D-serine could impact functional plasticity when pathological
conditions prevail as recently reported after traumatic brain
injury where the induction of SR expression in reactive astrocytes
associated with an excessive release of D-serine, impairs LTP
expression (Perez et al., 2017) and behavior (Liraz-Zaltsman
et al., 2018). Whether similar deleterious effects of glia-derived
D-serine on synaptic plasticity also occur in other astrogliosis-
associated brain injuries remains to be determined.
The SR-dependent modulation of functional plasticity
involves changes in NMDAR activation in response to altered
D-serine availability. Indeed, isolated NMDAR-dependent
excitatory postsynaptic currents (EPSCs) show slower
decay kinetics in SR−/− mice (Basu et al., 2009; Balu et al.,
2013) while the amplitude of miniature NMDAR-EPSCs are
significantly reduced in mice with selective neuronal SR deletion
(Benneyworth et al., 2012). Providing exogenous D-serine to
SR-deleted animals not only rescues these functional deficits but
also increases the amplitude of NMDAR-dependent currents
more extensively than in wild-type animals, consistent with
lower occupancy of the NMDAR glycine-binding site when SR is
invalidated.
SR is functionally modulated by a wide range of regulatory
mechanisms including changes in cofactors likely to be
present in the vicinity of the enzyme, protein interactions,
dynamic changes in subcellular localization and posttranslational
processes (recently reviewed and detailed in Wolosker, 2018).
An increase in SR activity, due to activation or the prevention
of its degradation, may be promoted by the small ligands
ATP and Mg2+ (De Miranda et al., 2002; Strísovský et al.,
2003; Foltyn et al., 2005), multiple protein interactors including
GRIP, Golga3, Disc-1 and FBXO22 (Kim et al., 2005; Dumin
et al., 2006; Ma et al., 2013; Dikopoltsev et al., 2014), by O-
palmitoylation-related processes (Balan et al., 2009) and also
possibly through phosphorylation at different residues (Balan
et al., 2009; Foltyn et al., 2010). On the other hand, nicotinamide
adeninedinucleotide (NADH) (Suzuki et al., 2015; Bruno et al.,
2016), protein interactions with Pick-1 (Fujii et al., 2006), PSD-
95 (Ma et al., 2014; Lin et al., 2016), SAP102 and stargazin (Ma
et al., 2014), membrane or nuclear translocations (Balan et al.,
2009; Kolodney et al., 2015) and S-Nitrosylation-related oxidative
processes (Mustafa et al., 2007) inhibit SR activity. Therefore, the
SR activity itself appears to be modulated in a complex manner
by a large mosaic of mechanisms, which can be targeted by the
aging process.
DOWN REGULATION OF SR-RELATED
ACTIVITY IN PHYSIOLOGICAL AGING
Changes in neurologic functions generally occur with
physiological aging that may substantially interfere with
everyday activities (Craik and Bialystok, 2006). Indeed, older
adults experience deficits in learning andmemory while the speed
of cognitive processing is frequently slowed down, that have
initially been associated with neuroanatomical changes (Brunso-
Bechtold et al., 2000; Driscoll et al., 2003; Finch, 2003; Geinisman
et al., 2004; Hayakawa et al., 2007; Burke and Barnes, 2010).
However, lessons from numerous preclinical investigations now
rather support the view that impaired expression of NMDAR-
dependent functional plasticity at synaptic connections is the
major cellular substrate of physiological cognitive aging (Lynch,
1998; Barnes, 2003; Billard, 2006; Foster, 2012). A decrease in
NMDAR density, and notably in GluN2B subunits, was initially
suspected to underlie LTP deficits in the aging brain (Magnusson,
1998, 2000; Clayton et al., 2002a,b; Magnusson et al., 2002; Bai
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FIGURE 2 | Schematic representation of the serine shuttle. L-serine specifically synthesized from glucose in the astrocyte subtype of glial cells, is released in external
medium through the Alanine, serine, cysteine, threonine (ASCT1) subtype of neutral amino acid transporters. It is then taken-up by neurons through the Asc-1 subtype
where it is converted into D-serine by serine racemase (SR) while part of the amino acid may be degraded into pyruvate and NH3 by α,β elimination of water. D-serine
is delivered back to extracellular space through Asc-1 hetero-exchange with L-serine to act on NMDAR thus promoting functional plasticity at synapses or
neurotoxicity in pathological conditions. D-serine is taken-up from the synaptic cleft through ASCT1 hetero-exchange with L-serine in astrocytes where it is degraded
by D-amino acid oxidase (DAAO) activity. Whether part of D-serine-derived astrocytes may be released to impact NMDAR is under debate.
et al., 2004; Brim et al., 2013) but defects affecting the functional
modulation of the receptor have also been later characterized
including deregulation at the redox site (Kuehl-Kovarik et al.,
2003; Bodhinathan et al., 2010; Yang et al., 2010; Kumar et al.,
2017), changes in non-competitive blockade (Norris and Foster,
1999) and even altered lipid composition of postsynaptic
membranes (Lynch and Voss, 1994; McGahon et al., 1999;
Latour et al., 2013). In the search of such functional deficits,
changes in SR-modulation of NMDAR activation has also been
postulated to develop with age (Billard, 2013). According to
this possibility, aged humans with impaired memory capacities
in the Groton maze computer test improve their performances
if they previously receive a D-serine-enriched drink (Avellar
et al., 2016) while learning deficits in aged drosophila in an
olfactory conditioning is rescued by feeding the flies with the
amino acid (Yamazaki et al., 2014). Subsequent analyses in aged
rodents indicate that a reduced SR expression is a prominent
feature of hippocampal aging (Figure 3A), which decreases
D-serine levels within neuronal networks and promotes NMDAR
hypofunction (Mothet et al., 2006; Potier et al., 2010; Turpin
et al., 2011). Providing the amino acid to the “aged” tissues
then restores NMDAR activation and LTP induction at synapses
(Yang et al., 2005; Mothet et al., 2006; Turpin et al., 2011). In
animal models of successful cognitive aging such as the LOU/C
strain of rats (Alliot et al., 2002; Kappeler et al., 2004), the potent
memory abilities and NMDAR-dependent LTP displayed by
aged individuals correlate with preserved SR expression and
D-serine production (Kollen et al., 2010; Turpin et al., 2011). One
characteristic of aged LOU/C rats is to present high resistance
to oxidative stress (OS) induced by the accumulation of free
radical damages that progressively take place in the course of
aging (Sohal and Weindruch, 1996; Golden et al., 2002; Ali
et al., 2006; Dröge and Schipper, 2007). Increased oxidation of
sulfydryl groups of SR (Mustafa et al., 2007) and/or changes in
its dimer active conformation (Wang and Barger, 2012) could
then be viewed as critical mechanisms driven by OS to impact SR
activation in the aging brain. Accordingly, long-term treatment
with the reducing agent N-acetyl cysteine in aged rats to prevent
from OS development, protects SR expression and activity and
preserves a potent NMDAR activation in the animals (Haxaire
et al., 2012). In addition, weaker SR activity promoted by OS
could also be managed through an hypermethylation in the
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FIGURE 3 | Serine racemase (SR) expression is down and up regulated in physiological and pathological brain aging respectively. (A) Examples of immunoblots for
serine racemase (SR) and α-tubulin in adult and aged rats (up) and bar graphs depicted the mean SR expression determined for each group when normalized to
α-tubulin (down). (B). Examples of immunoblots for SR and β-actin in a wild-type (WT) and an APP/PS1 mouse model of Alzheimer’s disease (up) and bar graphs
depicted the mean SR expression determined for each group when normalized to β-actin (down). (**P < 0.01). Modified with permissions from (Potier et al., 2010) and
(Madeira et al., 2015).
promoter of SR gene (Zhang et al., 2015) that could explain
the age-related decreased levels of SR transcripts (Mothet et al.,
2006; Potier et al., 2010). These results therefore reinforce the
idea of preventing oxidative stress as a major strategy to alleviate
cognitive aging (Sohal and Weindruch, 1996; Liu et al., 2003;
Dröge and Schipper, 2007).
Besides the OS-dependent dysfunctions of SR activation,
a down-regulation of its enzymatic activity could also be
viewed in the aging brain as resulting from a reduced synaptic
availability of L-serine (postulated in Ivanov and Mothet, 2018).
However, though the expression of PHGDH, one of the enzymes
predominantly involved in the synthesis pathway of the D-
serine precursor (Yamasaki et al., 2001), is reduced in acutely
isolated astrocytes from aged mice (Orre et al., 2014; Holtman
et al., 2015), overall levels of the amino acid are not altered
in the aging hippocampus (Mothet et al., 2006; Turpin et al.,
2011; Haxaire et al., 2012) and providing L-serine does not help
in preventing the age-related decrease in NMDAR activation
(Junjaud et al., 2006). On the other hand, recent evidence reports
that the D-serine shuttle, and notably the potency of the Asc-
1 transporters to release D-serine from neurons, is not affected
by age (Billard and Freret, 2018). These results further indicate
that changes in SR-related modulation of NMDAR represent a
critical mechanism associated with physiological brain aging and
that boosting SR activation could thus be viewed to represent an
alternative strategy to alleviate age-related memory impairment.
Among different possibilities, a strategy based on SR stimulation
by Mg2+ could be hypothesized considering that Mg2+ has been
shown to enhance learning and memory (Ozturk and Cillier,
2006; Slutsky et al., 2010).
UP REGULATION OF SR-RELATED
ACTIVITY IN ALZHEIMER’S DISEASE
Compared to other neurological disorders such as schizophrenia,
depression or amyotrophic lateral sclerosis (Goltsov et al., 2006;
Labrie and Roder, 2010; Mitchell et al., 2010; Gómez-Galán
et al., 2012; Balu and Coyle, 2015; Coyle and Balu, 2018),
our current knowledge on the role of the SR-related pathway
in the pathophysiology of Alzheimer’s disease (AD) is so far
limited. One reason for this weaker interest probably comes
from the initial biochemical observations indicating that free
D-serine levels were not consistently altered in the brain of
AD patients, although the percentage of D-serine in the total
(D + L) serine was significantly lower than that of aged-matched
controls (Chouinard et al., 1993; Kumashiro et al., 1995; Nagata
et al., 1995; Hashimoto et al., 2004; Biemans et al., 2016) but
see (Fisher et al., 1998). Nevertheless, the absence of a clear-cut
contribution of SR to AD-related pathophysiology could reflect
the fact that the levels of D-serine in those experiments were
determined in patients at late stages of the pathology whereas the
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most recent preclinical studies suggest that the amino acid could
rather be involved in the very early steps of the disease (Madeira
et al., 2015). Indeed, a significant increase in D-serine levels has
recently been characterized in the cerebrospinal fluid (CSF) of
subjects with only mild cognitive impairment that will probably
evolve into dementia (Madeira et al., 2015). This observation
has suggested that a deregulation of the SR-related activity could
serve as a new biomarker of the entry into the pathology [see
also (Hashimoto et al., 2004)], although this postulate has not
recently been confirmed (Biemans et al., 2016). Nevertheless,
several preclinical data strongly argue for the involvement of SR
in the pathophysiological processes underlying AD. Thus, two
major soluble factors involved in AD pathogenesis, the amyloid
ß-peptide (Aß) and the secreted form of ß-amyloid precursor
protein (APP) (Cline et al., 2018), stimulate SR expression and
promote D-serine release in microglial cell cultures whereas
these subtypes of glial cells do not normally produce the amino
acid (Wu et al., 2004, 2007). The Aß peptide evokes D-serine
synthesis and efflux also from neurons, in synergy with the
release of glutamate (Brito-Moreira et al., 2011; Madeira et al.,
2015) that drives over-stimulation of NMDAR and promotes
neurotoxicity, a typical picture of the pathophysiology of AD
(Harkany et al., 2000; Butterfield, 2002; Hynd et al., 2004). Several
other preclinical observations fit well with a contribution of D-
serine in AD-related neurotoxicity: neuronal cell death induced
by NMDA is strongly reduced in cerebral tissues depleted in D-
serine after a pre-treatment with DAAO (Katsuki et al., 2004)
as well as in organotypic hippocampal slices pre-treated with
the recombinant D-serine deaminase, an enzyme 100 fold more
active than DAAO in degrading the amino acid (Shleper et al.,
2005). In vivo, both NMDAR and Aß-induced neurotoxicity are
largely attenuated in SR−/− mice (Inoue et al., 2008). Through
the binding of inducible proto-oncogenes c-fos and JunB to the
activator protein-1 sequence present on the first intron of the SR
gene, Aß promotes the transcriptional induction of SR (Wu and
Barger, 2004), an observation which fits with the increase in SR
messenger RNAs in the brain of AD patients (Wu et al., 2004).
Post-transcriptional mechanisms may also contribute such as an
increase in intracellular calcium levels by Aß (Wu et al., 2004)
knowing that calcium overload in neurons is able to boost SR
activity (Cook et al., 2002; De Miranda et al., 2002).
Besides, a significant increase in SR expression and D-serine
levels also occur in vivo in a mouse model of AD with a
transgene for APP associated with a mutant form of presenilin
1 (APP/PS1 mice) (Figure 3B) (Madeira et al., 2015). Finally,
recent preliminary data indicate that in the 5xFAD model of AD
which expresses high levels of soluble Aß oligomers (Oakley et al.,
2006; Giannoni et al., 2013; Lee and Han, 2013), the impaired
functional plasticity reported at hippocampal synapses (Kimura
and Ohno, 2009; Crouzin et al., 2013) was rescued after deleting
the SR gene, that further points out a major role of an altered SR-
dependent modulation of NMDAR functions in the Aß-related
pathophysiology of AD (Billard et al., 2018).
Considering the current state of knowledge summarized
above, the elevated SR expression and the subsequent
increase in D-serine levels in the extracellular space could
be viewed as pro-death signals in AD that promotes, in
FIGURE 4 | Activity of serine racemase (SR) must be strictly regulated to avoid
age-related memory deficits. Schematic diagram outlying the concept that
although changes in SR expression and activity are opposite in physiological
and pathological brain aging brain through down- and up-regulation of
N-Methyl-D-Aspartic acid receptor (NMDAR) activity respectively, cognitive
deficits, and notably memory impairments, represent the ultimate syndrome in
both conditions.
conjunction with the release of glutamate, the neurotoxicity
exhibited by inflammatory processes (Barger et al., 2007;
Vesce et al., 2007). Although this view clearly remains to
be definitively characterized and notably if the glia-derived
SR could contribute to mechanisms of the insult, the up-
regulation of the SR-related pathway in AD therefore appears
as a perfect example of how a deregulation of allosteric
modulation of NMDAR may drive the onset of pathological
conditions.
CONCLUSION
Nowadays, a wealth of preclinical and clinical evidences argues
for a critical role of SR throughout lifespan in the regulation
of functional plasticity through the synaptic availability of
the NMDAR co-agonist D-serine. Such modulation impacting
NMDAR activation allows the enzyme to control many brain
functions in healthy conditions while being a preferential
target for pathophysiological insults (Coyle and Balu, 2018).
When interest is focused on age-related memory disabilities,
a down- and up-regulation of the SR-associated pathway
are specifically associated with physiological aging and AD
respectively. Although these alterations show striking opposite
directions, they both result in fine in memory deficits indicating
that a strict control of SR expression and activity is required
to achieve a successful cognitive aging (Figure 4). These results
therefore highlight SR as a potent target for the development
of alternative pharmacological interventions aimed at relieving
cognitive impairments linked to the aging process. Protection
of SR to the age-related oxidative stress is already suggested
to represent such an alternative procedure to rescue memory
deficits associated with physiological aging (Haxaire et al.,
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2012). In preclinical studies, SR antagonists such as Phenazine
Ethosulfate (Phen-Et) and erythro-β-Hydroxy L-aspartate have
been used to investigate SR involvement in specific NMDAR-
dependent processes (De Miranda et al., 2002; Kim et al.,
2005; Strísovský et al., 2005; Stevens et al., 2010), that could
represent other pharmacological alternatives to prevent the onset
of pathological conditions in which SR activity is facilitated
such as ALS, AD or brain trauma (Sasabe et al., 2007; Madeira
et al., 2015; Lee et al., 2017; Perez et al., 2017; Kondori et al.,
2018), though the specificity of these pharmacological tools
have recently been questioned. However, there is no doubt
now that increasing our knowledge of SR-dependent regulation
of NMDAR activation certainly represents a key route that
will help people keeping potent cognitive abilities throughout
lifespan.
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